TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial
Brief Summary: We aim to investigate the effectiveness and safety of nitrous oxide (N2O) in anaesthesia.

Hypothesis In patients undergoing anaesthesia for major surgery, avoidance of N2O will reduce hospital length of stay when compared with otherwise identically managed surgical patients receiving N2O as a component of their anaesthesia.


Options:
A: Intervention Type: DRUG; Name: Nitrous Oxide; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
C: Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Arm Label: Propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Propofol | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam
D: Arm Label: Esmolol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Esmolol, Drug: Propofol and sevoflurane | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Esmolol; Assigned to Arm(s): Esmolol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): control | Intervention Type: DRUG; Name: Propofol and sevoflurane; Assigned to Arm(s): Esmolol

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial
Brief Summary: We aim to investigate the effectiveness and safety of nitrous oxide (N2O) in anaesthesia.

Hypothesis In patients undergoing anaesthesia for major surgery, avoidance of N2O will reduce hospital length of stay when compared with otherwise identically managed surgical patients receiving N2O as a component of their anaesthesia.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: air | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Nitrous oxide | Intervention Type: DRUG; Name: air; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Nitrous oxide; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Nitrous Oxide; Assigned to Arm(s): N/A
D: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial
Brief Summary: We aim to investigate the effectiveness and safety of nitrous oxide (N2O) in anaesthesia.

Hypothesis In patients undergoing anaesthesia for major surgery, avoidance of N2O will reduce hospital length of stay when compared with otherwise identically managed surgical patients receiving N2O as a component of their anaesthesia.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen by mask | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen by mask | Intervention Type: OTHER; Name: Oxygen by mask; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Oxygen by mask; Assigned to Arm(s): 2
B: Intervention Type: DRUG; Name: Nitrous Oxide; Assigned to Arm(s): N/A
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): A, B
D: Arm Label: 70% Nitrous Oxide; Type: OTHER; Interventions: Other: Nitrous Oxide | Arm Label: No Nitrous Oxide; Type: OTHER; Interventions: Other: No Nitrous Oxide | Intervention Type: OTHER; Name: Nitrous Oxide; Assigned to Arm(s): 70% Nitrous Oxide | Intervention Type: OTHER; Name: No Nitrous Oxide; Assigned to Arm(s): No Nitrous Oxide

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-Controlled Study of Limited vs. Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Brief Summary: This is a randomized, blinded, two-arm comparative trial of continued versus limited isoniazid (INH) tuberculosis (TB) preventive therapy in HIV-infected adults in Gaborone and Francistown, Botswana. Subjects will be accrued over two years and followed for a minimum of 36 months.


Options:
A: Intervention Type: DRUG; Name: I ( isoniazid), II (isoniazid + rifampin ); Assigned to Arm(s): N/A
B: Arm Label: Continuous vs limited isoniazid; Type: EXPERIMENTAL; Interventions: Drug: Isoniazid | Intervention Type: DRUG; Name: Isoniazid; Assigned to Arm(s): Continuous vs limited isoniazid
C: Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: isoniazid , randomized, open label, Drug: rifampin, randomized, open label | Intervention Type: DRUG; Name: isoniazid , randomized, open label; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: rifampin, randomized, open label; Assigned to Arm(s): 1
D: Arm Label: HIVneg/INH; Type: EXPERIMENTAL; Interventions: Drug: Isoniazid (INH), Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX) | Arm Label: HIVneg/PL; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isoniazid Placebo (PL) | Arm Label: HIVpos/INH; Type: EXPERIMENTAL; Interventions: Drug: Isoniazid (INH), Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX) | Arm Label: HIVpos/PL; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isoniazid Placebo (PL) | Intervention Type: DRUG; Name: Isoniazid (INH); Assigned to Arm(s): HIVneg/INH, HIVpos/INH | Intervention Type: DRUG; Name: Trimethoprim/Sulfamethoxazole (TMP/SMX); Assigned to Arm(s): HIVneg/INH, HIVpos/INH | Intervention Type: DRUG; Name: Isoniazid Placebo (PL); Assigned to Arm(s): HIVneg/PL, HIVpos/PL

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)
Brief Summary: The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.


Options:
A: Intervention Type: BEHAVIORAL; Name: Peer Education Intervention; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Methadone | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): A, B
D: Intervention Type: BEHAVIORAL; Name: Behavior Therapy; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HIP: HIV Intervention for Providers
Brief Summary: The purpose is to encourage Provider participants to evaluate high risk HIV transmission behaviors and offer prevention messages to their HIV+ patients which will, in turn, reduce rates of unprotected anal and/or vaginal sex with partners of known HIV sero-negativity or unknown HIV serostatus. It is hypothesized that patients of providers participating in the HIP intervention will report higher reduction in sexual risk practices, when compared to the patients of the providers who were randomized into the control condition.


Options:
A: Arm Label: Implementation intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation intervention; Assigned to Arm(s): Implementation intervention
B: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Provider Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: RDTs & Provider Training on Malaria Diagnosis and Treatment | Arm Label: Extended intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: RDTs & Provider Training on Malaria Diagnosis and Treatment, Behavioral: Extended provider training (Cameroon only), Behavioral: School based malaria education (Nigeria only) | Intervention Type: BEHAVIORAL; Name: RDTs & Provider Training on Malaria Diagnosis and Treatment; Assigned to Arm(s): Extended intervention, Provider Intervention | Intervention Type: BEHAVIORAL; Name: Extended provider training (Cameroon only); Assigned to Arm(s): Extended intervention | Intervention Type: BEHAVIORAL; Name: School based malaria education (Nigeria only); Assigned to Arm(s): Extended intervention
D: Intervention Type: BEHAVIORAL; Name: HIP: HIV Intervention for Providers; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Episodic Acyclovir Therapy on Ulcer Duration and HIV Shedding From Genital Ulcers Among Men in South Africa
Brief Summary: The purpose of this study is to determine if acyclovir episodic treatment has an effect in ulcer healing and if it should be added to the syndromic management of genital ulcer disease.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Acyclovir | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Acyclovir placebo | Intervention Type: DRUG; Name: Acyclovir; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Acyclovir placebo; Assigned to Arm(s): 2
B: Arm Label: Acyclovir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Generic acyclovir | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Generic acyclovir; Assigned to Arm(s): Acyclovir | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: valacyclovir | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: valacyclovir; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
D: Intervention Type: DRUG; Name: Acyclovir; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Tools for Health Promotion and Disease Prevention
Brief Summary: The study will evaluate the effect of familial risk assessment and prevention prompts tailored to familial risk on health behaviors and use of preventive services among adults who are members of primary care practices in the U.S.


Options:
A: Arm Label: Culturally-tailored video; Type: OTHER; Interventions: Behavioral: Culturally-tailored video | Intervention Type: BEHAVIORAL; Name: Culturally-tailored video; Assigned to Arm(s): Culturally-tailored video
B: Intervention Type: BEHAVIORAL; Name: Familial risk assessment and personalized prevention messages; Assigned to Arm(s): N/A
C: Arm Label: Mailed printed materials and in-office training; Type: EXPERIMENTAL; Interventions: Behavioral: Mailed printed materials and in-office training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mailed printed materials and in-office training; Assigned to Arm(s): Mailed printed materials and in-office training
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: non needle control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Accupuncture | Arm Label: Acupuncture - Standardized Points; Type: SHAM_COMPARATOR; Interventions: Procedure: Accupuncture | Arm Label: Accupunture - Experimental Points; Type: EXPERIMENTAL; Interventions: Procedure: Accupuncture | Intervention Type: PROCEDURE; Name: Accupuncture; Assigned to Arm(s): Accupunture - Experimental Points, Acupuncture - Standardized Points, non needle control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Legacy for Children, The CDC Parenting Research Projects
Brief Summary: The purpose of this study is to determine if an intervention focused on promoting parent-child interaction, parental responsibility, parental commitment of time and energy, and sense of community results in better developmental outcomes for low-income children.


Options:
A: Arm Label: Intervention Chicago Parent Program arm; Type: EXPERIMENTAL; Interventions: Behavioral: Chicago Parent Program | Arm Label: Parent-Child Interaction Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Parent-Child Interaction Therapy | Intervention Type: BEHAVIORAL; Name: Chicago Parent Program; Assigned to Arm(s): Intervention Chicago Parent Program arm | Intervention Type: BEHAVIORAL; Name: Parent-Child Interaction Therapy; Assigned to Arm(s): Parent-Child Interaction Therapy
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Incredible Years Program | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Incredible Years Program | Intervention Type: BEHAVIORAL; Name: Incredible Years Program; Assigned to Arm(s): 1, 2
C: Arm Label: Family Startup; Type: EXPERIMENTAL; Interventions: Other: Family Startup (in Danish: Familieiværksætterne) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Family Startup (in Danish: Familieiværksætterne); Assigned to Arm(s): Family Startup
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting group | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parenting group; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nevirapine Pharmacodynamics and Resistance Among HIV-Infected Mothers in Lilongwe, Malawi
Brief Summary: The purpose of this study is to determine whether the addition of zidovudine (ZDV) and lamivudine (3TC) at the onset of labor and for up to seven days postpartum to single-dose nevirapine (NVP) is associated with a lower prevalence of NVP-resistant HIV compared to single-dose NVP without ZDV+3TC.


Options:
A: Intervention Type: DIETARY_SUPPLEMENT; Name: fortified spread (RUTF); Assigned to Arm(s): N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: maize and soy flour; Assigned to Arm(s): N/A
B: Arm Label: MSPP Integrated Package; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nutributter 3 Months, Integrated Package; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nutributter Program, Other: Integrated Package | Arm Label: Nutributter 6 Months, Integrated Package; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nutributter Program, Other: Integrated Package | Intervention Type: DIETARY_SUPPLEMENT; Name: Nutributter Program; Assigned to Arm(s): Nutributter 3 Months, Integrated Package, Nutributter 6 Months, Integrated Package | Intervention Type: OTHER; Name: Integrated Package; Assigned to Arm(s): Nutributter 3 Months, Integrated Package, Nutributter 6 Months, Integrated Package
C: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Lopinavir/ritonavir, Drug: Zidovudine, Drug: Lamivudine | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Efavirenz, Drug: Zidovudine, Drug: Lamivudine | Intervention Type: DRUG; Name: Lopinavir/ritonavir; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): Group B | Intervention Type: DRUG; Name: Zidovudine; Assigned to Arm(s): Group A, Group B | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): Group A, Group B
D: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Administration of Intravenous Proton Pump Inhibitor Prior to Endoscopy [APPE] in Patients With Upper Gastrointestinal Bleeding; a Double-Blind Placebo-Controlled Randomised Study.
Brief Summary: To evaluate if intravenous PPI infusion, when administered prior to endoscopy, hastens resolution of bleeding stigmata and thereby facilitates endoscopic examinations and reduces the need for endoscopic treatment. Clot stabilization may itself sustain control of bleeding before endoscopy. These may translate into improved patients'outcome and survival.

To determine the therapeutic effect of high-dose PPI infusion in upper gastrointestinal bleeding from causes other than peptic ulcers.


Options:
A: Intervention Type: DRUG; Name: Esomeprazole; Assigned to Arm(s): N/A
B: Arm Label: lansoprazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: lansoprazole | Arm Label: esomeprazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole | Intervention Type: DRUG; Name: lansoprazole; Assigned to Arm(s): lansoprazole | Intervention Type: DRUG; Name: esomeprazole; Assigned to Arm(s): esomeprazole
C: Intervention Type: DRUG; Name: Omeprazole; Assigned to Arm(s): N/A
D: Arm Label: Double oral dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden) | Arm Label: Regular oral dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden) | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden) | Intervention Type: DRUG; Name: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden); Assigned to Arm(s): Control group, Double oral dose, Regular oral dose

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Parent-Youth Teamwork in Pediatric Asthma Management
Brief Summary: The purpose of this research study is to examine the effectiveness of a parent-youth teamwork treatment and an asthma education treatment in helping children use their asthma medicines correctly. We also want to learn about how these treatments affect parental involvement in asthma care, parent and youth relationships, and children's health care.


Options:
A: Arm Label: peer-led asthma self-managment program; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-assisted asthma self-management program | Arm Label: Adult-led asthma self-management program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adult-led asthma self-management program | Intervention Type: BEHAVIORAL; Name: Peer-assisted asthma self-management program; Assigned to Arm(s): peer-led asthma self-managment program | Intervention Type: BEHAVIORAL; Name: Adult-led asthma self-management program; Assigned to Arm(s): Adult-led asthma self-management program
B: Arm Label: Nurse group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Arm Label: Lay educator group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Intervention Type: BEHAVIORAL; Name: Self management education; Assigned to Arm(s): Lay educator group, Nurse group
C: Intervention Type: DEVICE; Name: electronic medication monitoring system; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: parent-adolescent communication and problem-solving skills; Assigned to Arm(s): N/A
D: Arm Label: community health worker; Type: EXPERIMENTAL; Interventions: Behavioral: community health worker | Arm Label: mailed information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: mailed information | Intervention Type: BEHAVIORAL; Name: community health worker; Assigned to Arm(s): community health worker | Intervention Type: BEHAVIORAL; Name: mailed information; Assigned to Arm(s): mailed information

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Parent-Youth Teamwork in Pediatric Asthma Management
Brief Summary: The purpose of this research study is to examine the effectiveness of a parent-youth teamwork treatment and an asthma education treatment in helping children use their asthma medicines correctly. We also want to learn about how these treatments affect parental involvement in asthma care, parent and youth relationships, and children's health care.


Options:
A: Arm Label: Speech recognition (TEAM intervention); Type: EXPERIMENTAL; Interventions: Behavioral: Speech recognition | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Speech recognition; Assigned to Arm(s): Speech recognition (TEAM intervention)
B: Intervention Type: DEVICE; Name: electronic medication monitoring system; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: parent-adolescent communication and problem-solving skills; Assigned to Arm(s): N/A
C: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms
D: Arm Label: Interventional group: Period 2; Type: EXPERIMENTAL; Interventions: Drug: salmeterol/fluticasone propionate 50/250 µg + 3 training sessions of compliance enhancement training | Arm Label: Control group: Period 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: salmeterol/fluticasone propionate 50/250 µg | Arm Label: Subjects receiving salmeterol/fluticasone propionate: Period 1; Type: EXPERIMENTAL; Interventions: Drug: salmeterol/fluticasone propionate 50/250 µg | Intervention Type: DRUG; Name: salmeterol/fluticasone propionate 50/250 µg + 3 training sessions of compliance enhancement training; Assigned to Arm(s): Interventional group: Period 2 | Intervention Type: DRUG; Name: salmeterol/fluticasone propionate 50/250 µg; Assigned to Arm(s): Control group: Period 2, Subjects receiving salmeterol/fluticasone propionate: Period 1

Answer: B